Verici Dx Achieves Nationwide Access Following New York State Approval
FRANKLIN, Tenn., June 24, 2026 Verici Dx plc announced that it has received clinical laboratory accreditation from the New...
AI drug discovery artificial intelligence Autoimmune Disease biologics Biomarkers biopharma Biopharmaceuticals Biotechnology Bispecific Antibody Cancer Immunotherapy Cancer Research cancer therapy Cell Therapy Clinical Development Clinical Research clinical trial clinical trials Digital Health drug development Drug Discovery EMA FDA fda approval FDA clearance Gene Therapy Healthcare Innovation healthcare technology immunology Immunotherapy Medical Devices MedTech Monoclonal Antibody Neurodegenerative Disease Neurology Oncology Orphan Drug Phase 1 trial Phase 2 Trial Phase 3 Phase 3 trial Precision Medicine Precision Oncology rare disease Regenerative Medicine targeted therapy
FRANKLIN, Tenn., June 24, 2026 Verici Dx plc announced that it has received clinical laboratory accreditation from the New...
SECAUCUS, N.J., June 24, 2026 Quest Diagnostics announced that the New York State Department of Health’s Clinical Laboratory Evaluation...
IRVING, Texas, May 8, 2026 Caris Life Sciences® has submitted an application to the New York State Department of...
